Aim: Robotic myomectomy (RM) is a newer modality of minimally invasive surgery. As compared to laparoscopic myomectomy (LM), there is greater ease, accessibility, and precision for surgeons and fewer intra and postoperative (post-op) complications. This study aims at evaluating and comparing the short-term surgical outcomes of RM and LM. Materials and methods: A retrospective observational study was conducted from September 2016 to August 2019. A total of 35 study participants, 14 cases who underwent LM and 21 cases who underwent RM, were included. Variables like size and number of myomas, intraoperative blood loss, operating time, short-term surgical outcomes such as duration of hospital stay, need for blood transfusion, and complications were noted and analyzed. The mean of the two groups was compared using a two-sample unpaired t-test, and a p-value of <0.05 was considered statistically significant. Result: The mean age of study participants who underwent LM was 33.7 ± 5.5 years, and for RM was 32.3 ± 5.6 years. The mean surgical or operating time was 184.6 ± 9.2 and 300 ± 14.1 minutes in LM and RM, respectively. The estimated blood loss was 395.7 ± 78 mL and 255 ± 123.5 mL in LM and RM, respectively, which was statistically significant. The number of days of hospital stay postsurgery were 3.9 ± 1.1 and 2.2 ± 1.4 days in LM and RM, respectively, which was statistically significant. The average size of myoma in LM was 6.3 ± 1.2 cm, whereas in RM was 9.2 ± 1.3 cm. Conclusion: Removal of bigger, multiple fibroids, and myomas at difficult locations was made easier with less blood loss by RM when compared to LM. Short-term surgical outcomes were better in RM as compared to LM. Clinical significance: Robotic myomectomy (RM) has been shown to reduce immediate post-op complications and helps in faster recovery and discharge from the hospital as compared to LM.